Blog
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Johnson & Johnson (JNJ) closed the most recent trading day at $238.11, moving -2.09% from the previous trading session. This change lagged the S&P 500's 0.25% gain on the day. Elsewhere, the Dow
Intel (INTC) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Intel (INTC) closed at $44.06, marking a -3.72% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.25% for the day. At the
NextNav Inc. (NN) Reports Q4 Loss, Beats Revenue Estimates
NextNav Inc. (NN) came out with a quarterly loss of $0.13 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.25 per share a year ago. These figures are adjusted for
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.2 per share a year ago. These
Titan America (TTAM) Q4 Earnings and Revenues Lag Estimates
Titan America (TTAM) came out with quarterly earnings of $0.24 per share, missing the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.21 per share a year ago. These
Adient (ADNT) and Johnson Control International (JCI) Are Aggressive Growth Stocks
As the aggressive growth stock strategist at Zacks Investment Research Brian Bolan usually looks for stocks that have a strong Zacks Style Score for Growth and a weak Zacks Style Score for Value
Lululemon (LULU) Tops Q4 Earnings and Revenue Estimates
Lululemon (LULU) came out with quarterly earnings of $5.01 per share, beating the Zacks Consensus Estimate of $4.76 per share. This compares to earnings of $6.14 per share a year ago. These figures
Energy Vault Holdings, Inc. (NRGV) Reports Q4 Loss, Tops Revenue Estimates
Energy Vault Holdings, Inc. (NRGV) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to a loss of $0.35 per share a year ago
DocuSign (DOCU) Beats Q4 Earnings and Revenue Estimates
DocuSign (DOCU) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.86 per share a year ago. These figures
HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.69 per share a year ago. These
Gossamer Bio (GOSS) Reports Q4 Loss, Beats Revenue Estimates
Gossamer Bio (GOSS) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.15 per share a year ago. These figures are
Micron Continues to Display The Power of the Zacks Rank
Micron MU is a world leader in innovative memory and storage solutions that accelerate the transformation of information into intelligence. Shares have been red hot on the back of the AI frenzy
Top Stock Reports for GE Aerospace, Shell & McKesson
Tuesday, March 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including GE Aerospace
Howmet's Defense Aerospace Strength Seems Firm: More Upside Ahead?
Howmet Aerospace Inc. HWM is poised to gain from the expanding defense budget, which remains a key growth catalyst. In the fourth quarter of 2025, revenues from the defense aerospace market rose 20%
CSCO Taps NVIDIA to Drive Secure AI at the Edge: More Upside Ahead?
Cisco Systems CSCO is expanding its Secure AI Factory with NVIDIA Corporation (NVDA), which will enable enterprises to run AI everywhere instead of only in large data centers. The expanded solution
AIG Expands Specialty Reach With McGill Tie-Up, Targets $1.6B Book
American International Group, Inc. AIG recently entered into a long-term strategic partnership with McGill and Partners. The goal is to modernize specialty insurance using data and digital tools
Best Value Stocks to Buy Now and How to Find Them
No one knows what’s right around the corner given the geopolitical turmoil. Still, stocks jumped slightly through morning trading on Tuesday after the Nasdaq and the S&P 500 charged higher to start
FEIM's Q3 Earnings Down Y/Y Due to Margin Pressure, Backlog Grows
Shares of Frequency Electronics, Inc. FEIM have declined 11.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index, which fell 2.1% over
NU's Post-Earnings Dip Despite Strong Results: A Buying Opportunity?
Sometimes it helps to step back after results are out and let the market digest the numbers before concluding. Following its late-February earnings release, Nu Holdings NU saw its stock slide
Tredegar's Q4 Earnings Soar Y/Y on Aluminum Extrusions Strength
Shares of Tredegar Corporation TG have underperformed the broader market following the release of its fourth-quarter results. The stock has declined 3.4% since the earnings announcement for the
Best Momentum Stocks on the Zacks Rank (CIEN, MU, CENX)
There is always a bull market somewhere.
Despite shifting headlines and constantly evolving market narratives, certain stocks and sectors continue to benefit from prevailing economic regimes. In the
RGA Offers Upside on Strong Growth Prospects - Buy or Hold the Stock?
Reinsurance Group of America RGA is a leading global provider of traditional life and health reinsurance, as well as financial solutions, with operations across the United States, Latin America
KROS: Is the Discount Book Value a Value Trap?
Keros Therapeutics KROS posted a dramatic revenue jump in 2025, but the mix matters as much as the magnitude. The shares also trade at a steep discount to book value, creating the classic biotech
KROS Stock: What to Know About Rinvatercept in DMD
Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program


